Description

PT-141 (Bremelanotide)

Introduction

PT-141, also known as Bremelanotide, is a synthetic cyclic peptide and melanocortin receptor agonist. It is manufactured under controlled production conditions using established quality management systems. Pharmaceutical-grade Bremelanotide undergoes comprehensive analytical testing to help ensure identity, purity, and manufacturing consistency before release.

Depending on the manufacturer and approved presentation, PT-141 may be supplied as a sterile injectable formulation. Products are packaged using pharmaceutical-grade materials to help maintain product quality during storage and transportation.


Product Overview

Specification Details
Product Name PT-141 (Bremelanotide)
Category Synthetic Peptide
Peptide Type Melanocortin Receptor Agonist
Form Sterile Injectable Solution*
Appearance Clear, Colorless Solution or Lyophilized Powder*
Purity Batch Specific
Packaging Sterile Glass Vial or Prefilled Device*
Storage Store Refrigerated at 2°C–8°C or as Specified by the Manufacturer

*Product presentation may vary depending on the manufacturer and market.


Manufacturing Standards

PT-141 is produced using controlled peptide synthesis and advanced purification techniques designed to support formulation consistency and product quality.

Manufacturing processes commonly include:

  • Precision peptide synthesis
  • Advanced purification methods
  • Controlled manufacturing environments
  • Sterile filling procedures
  • Batch traceability
  • Comprehensive analytical quality testing

Quality Assurance

Each production batch is typically evaluated through quality control procedures that may include:

  • Identity verification
  • Purity assessment
  • Appearance inspection
  • Stability evaluation
  • Batch consistency testing
  • Packaging inspection

These procedures help support reliable manufacturing standards and product integrity.


Physical Characteristics

Typical characteristics include:

  • Clear, colorless sterile solution or white to off-white lyophilized powder
  • Stable formulation under recommended storage conditions
  • Uniform product appearance
  • Sterile presentation
  • Clearly labeled packaging

Packaging

Products are generally supplied in protective pharmaceutical packaging that may include:

  • Sterile sealed glass vial or prefilled device
  • Tamper-evident closure
  • Product identification label
  • Batch number for traceability
  • Protective outer packaging

Storage Recommendations

To help preserve product quality:

  • Store according to the manufacturer’s recommended storage conditions.
  • Protect from direct sunlight.
  • Avoid excessive heat and moisture.
  • Keep the container tightly sealed until use.
  • Store in the original packaging.
  • Do not use if the container or seal has been damaged.

Product Features

  • Synthetic cyclic peptide
  • Controlled peptide manufacturing
  • Advanced purification technology
  • Comprehensive analytical quality testing
  • Batch traceability
  • Sterile pharmaceutical packaging
  • Stable formulation under recommended storage conditions
  • Professional manufacturing standards